The structural basis of the autoinhibition mechanism of glycogen synthase kinase 3β (GSK3β): molecular modeling and molecular dynamics simulation studies.

GSK3β MD simulations allosteric regulation allostery autoinhibition binding free energy

Journal

Journal of biomolecular structure & dynamics
ISSN: 1538-0254
Titre abrégé: J Biomol Struct Dyn
Pays: England
ID NLM: 8404176

Informations de publication

Date de publication:
Apr 2020
Historique:
pubmed: 7 5 2019
medline: 22 6 2021
entrez: 7 5 2019
Statut: ppublish

Résumé

The autoinhibition phenomenon has been frequently observed in enzymes and represents an important regulatory strategy to fine-tune enzyme activity. Evolution has exploited this mechanism to reduce enzymatic activity. Glycogen synthase kinase 3β (GSK3β) undergoes autoinhibition via the phosphorylation of Ser9 at the N-terminus of the kinase, which, acting as a pseudosubstrate, occupies the catalytic domain of GSK3β and subsequently blocks primed substrates from having access to the catalytic domain. The detailed structural basis of the autoinhibition mechanism of GSK3β by the pseudosubstrate, however, has not yet been fully resolved. Here, a three-dimensional model of the binary GSK3β-pseudosubstrate complex was built via the molecular modeling method. Based on the constructed model, extensive molecular dynamics (MD) simulations and subsequent molecular mechanics generalized Born/surface area (MM_GBSA) calculations were performed on the wild-type GSK3β-pseudosubstrate complex and three mutated systems (R4A, R6A, and S9A). Analyses of MD simulations and binding free energies revealed that the phosphorylation of Ser9 is the prerequisite for the autoinhibition of GSK3β, and both mutations of Arg4 and Arg6 to alanine markedly reduced the binding affinities of the mutated pseudosubstrate to the GSK3β catalytic domain, thereby disrupting the autoinhibition of the kinase. This study highlights the importance of Ser9, Arg6, and Arg4 in modulating the autoinhibition mechanism of GSK3β, contributing to a deeper understanding of GSK3β biology.Communicated by Ramaswamy H. Sarma.

Identifiants

pubmed: 31057052
doi: 10.1080/07391102.2019.1615988
doi:

Substances chimiques

Glycogen Synthase Kinase 3 beta EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1741-1750

Auteurs

Linkai Mou (L)

Department of Urology, Affiliated Hospital of Weifang Medicinal University, Weifang, Shandong, China.

Wenwen Dou (W)

Department of Infectious Diseases, Affiliated Hospital of Weifang Medicinal University, Weifang, Shandong, China.

Gang Meng (G)

Department of Urology, Affiliated Hospital of Weifang Medicinal University, Weifang, Shandong, China.

Ke Sun (K)

Department of Urology, Affiliated Hospital of Weifang Medicinal University, Weifang, Shandong, China.

Xiangyu Chen (X)

Department of Laboratory Medicine, Weifang Medicinal University, Weifang, Shandong, China.

Articles similaires

Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis

Classifications MeSH